Drug intelligence / Profile preview

oleanolic acid-zinc complex

Development stage
Preclinical
Lead developer
Sağlık Bilimleri Üniversitesi
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Administration
Oral
01

Overview

**Oleanolic acid-zinc complex** is an experimental zinc coordination complex of oleanolic acid, a pentacyclic triterpenoid. In an ovalbumin-induced rat model of allergic asthma, it reduced airway inflammatory responses, including delayed-type hypersensitivity, inflammatory-cell accumulation, immunoglobulin E, cyclooxygenase-2, 5-lipoxygenase, nitric oxide, splenocyte proliferation, and pulmonary expression of several inflammatory mediators. The reported activity is preclinical and appears to reflect broad anti-inflammatory and immunomodulatory effects; no direct molecular binding target, clinical development program, marketed product, or human dosing formulation has been established.

Other names
OA + Znoleanolic acid-zinc complexzinc complex of oleanolic acid
02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NF-κBTLR2 (Toll-like Receptor 2)TNFA (Tumor necrosis factor alpha (soluble))IL-13 (Interleukin-13)IL-17A (Interleukin-17A)IL-4 (Interleukin 4)IL-5 (Interleukin 5)

Beyond the preview

Go deeper on oleanolic acid-zinc complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oleanolic acid-zinc complex.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call